Increasing Use of the Vaccine Against Herpes Zoster/Shingles at NYULMC and Bellevue Hospital

Not Applicable

Completed

• Conditions: Herpes Zoster
• Interventions: Other: Choosing to receive the vaccine

• Registration Number: NCT01483378
• Lead Sponsor: NYU Langone Health

Brief Summary

The purpose of this study is to determine if vaccination rate of eligible patients at a major urban public hospital will increase by having ophthalmologists screen patients for eligibility and a nurse administer the vaccine in the General Eye Clinic.

Detailed Description

Patient vaccination behaviors will be assessed after 100 doses of the Zostavax vaccine are provided to underserved patients screened by ophthalmologists at the General Eye Clinic at a public hospital that does not normally provide the vaccine. A nurse will be at the clinic to administer the vaccine. Patients will be contacted by phone 1 month later and seen within 3 months in the Eye Clinic to determine whether there were any side effects.

Study Timeline

• Study First Submitted: 2011-11-18
• Study First Submitted QC: 2011-11-30
• Study First Posted: 2011-12-01
• Study Start: 2012-01
• Primary Completion: 2012-02
• Study Completion: 2012-02
• Results First Submitted: 2013-02-19
• Status Verified: 2013-08
• Results First Submitted QC: 2013-08-07
• Last Update Submitted: 2013-08-07
• Results First Posted: 2013-08-09
• Last Update Posted: 2013-08-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 170

Inclusion Criteria

• 60 years of age or older
• Absence of evidence of immune compromise in the medical record
• Ability to speak and read English, Spanish or Chinese and give informed consent

Exclusion Criteria

• Vulnerable patients, including the cognitively impaired, prisoners and employee
• FDA contraindications for Zostavax vaccine

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Subjects who received the vaccine	Choosing to receive the vaccine	Patients in this arm were eligible for the herpes zoster vaccine and chose to receive it.

Primary Outcome Measures

Name	Time	Method
Answers to Survey Questions	January 9, 2012 to February 12, 2012	All enrolled patients completed a survey of baseline characteristics, eligibility for the herpes zoster vaccine, and attitudes regarding herpes zoster vaccination. The survey results from patients who agreed to receive the herpes zoster vaccine were compared to the results of patients who declined to be vaccinated.

Trial Locations

Locations (2)

Bellevue Hospital; 🇺🇸 New York, New York, United States

NYU Langone Medical Center; 🇺🇸 New York, New York, United States